Hot New Products Carbonitrile - Pirfenidone CAS 53179-13-8 Purity ≥99.0% IPF – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

High quality Very first,and Shopper Supreme is our guideline to offer the most beneficial company to our clients.Nowadays, we're hoping our best to be certainly one of the top exporters in our area to satisfy consumers additional will need for Darifenacin hydrobromide CAS 133099-07-7, 86728-85-0, C7H2ClF3O2, We are looking forward to establishing cooperative relationships with you. Please contact us for more information.
Hot New Products Carbonitrile - Pirfenidone CAS 53179-13-8 Purity ≥99.0% IPF – Ruifu Detail:

Supply With High Purity, Commercial Production 
Chemical Name: Pirfenidone 
CAS: 53179-13-8

Chemical Name Pirfenidone
Synonyms Perfenidone; 5-Methyl-1-Phenylpyridine-2(1H)-one; PFD; S-7701; AMR-69
CAS Number 53179-13-8
CAT Number RF-API108
Stock Status In Stock 
Molecular Formula C12H11NO
Molecular Weight 185.22
Melting Point  96.0 to 97.0℃
Solubility  Soluble in DMSO
Brand Ruifu Chemical
Item Specifications
Appearance White to Light Yellow Crystalline Powder
Identification IR
Purity ≥99.0%
Loss on Drying ≤0.50%
Sulfated Ash ≤0.20%
Single Impurity ≤0.50%
Total Impurities ≤1.0%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage API, Idiopathic Pulmonary Fibrosis (IPF)

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

1

Pirfenidone (CAS: 53179-13-8) is in a group of medicines called antifibrotic agents. Pirfenidone has demonstrated activity in multiple fibrotic conditions, including those of the lung, kidney and liver. It affects your body’s immune system and reduces the amount of fibrosis (scarring) in the lungs. Pirfenidone is one of two medicines that are approved in Canada to treat Idiopathic Pulmonary Fibrosis (IPF). Pirfenidone is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties. It was first approved in Japan for the treatment of patients with idiopathic pulmonary fibrosis after clinical trials, under the trade name of Pirespa by Shionogi, in 2008. It was approved for use in the European Union in 2011, in Canada in 2012, and in the United States in October 2014.  


Product detail pictures:

Hot New Products Carbonitrile - Pirfenidone CAS 53179-13-8 Purity ≥99.0% IPF – Ruifu detail pictures


Related Product Guide:

Assume full duty to satisfy all demands of our clients; reach steady advancements by marketing the development of our purchasers; grow to be the final permanent cooperative partner of clientele and maximize the interests of customers for Hot New Products Carbonitrile - Pirfenidone CAS 53179-13-8 Purity ≥99.0% IPF – Ruifu , The product will supply to all over the world, such as: Nairobi, Libya, Nepal, At Present, our merchandise have been exported to more than sixty countries and different regions, such as Southeast Asia, America, Africa, Eastern Europe, Russia, Canada etc. We sincerely hope to establish wide contact with all potential customers both in China and the rest part of the world.
  • This is a very professional wholesaler, we always come to their company for procurement, good quality and cheap.
    5 Stars By Cora from French - 2017.08.28 16:02
    This company has a lot of ready-made options to choose and also could custom new program according to our demand, which is very nice to meet our needs.
    5 Stars By Judith from Los Angeles - 2018.12.28 15:18
    Write your message here and send it to us